Skip to content

Clinical trials

Phase 4 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 4 Country / region: New Zealand Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20037
20046
20055
20067
20072
20089
20095
20101
20113
20124
20132
20148
20152
20163
20173
20182
20191
20202
20211
20222
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated9
Recruiting8
Unknown status6
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche9
Pfizer7
Boehringer Ingelheim5
DePuy International4
GlaxoSmithKline4
The George Institute3
University of Auckland, New Zealand3
Wyeth is now a wholly owned subsidiary of Pfizer3
Kirby Institute2
Monash University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 27
Coronary Artery Disease5
Osteoarthritis5
Cardiovascular Diseases4
Arthritis, Rheumatoid3
Hepatitis B, Chronic3
Hepatitis C, Chronic3
Hypertension3
Myocardial Infarction3
Sepsis3

Trials

Showing 26 to 50 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.